- ►shouxi.net LL Baggio, D Holland, J Wither, DJ Drucker - Diabetes, 2006 - Am Diabetes Assoc Glucagon-like peptide 1 (GLP-1) exhibits considerable potential for the
treatment of type 2 diabetes because of its effects on stimulation of insulin
secretion and the inhibition of gastric emptying, appetite, and glucagon ... Cited by 4 - Related articles - BL Direct - All 6 versions
SL Samson, EV Gonzalez, V Yechoor, M Bajaj … - Molecular therapy: the journal of the American Society …, 2008 - pubmedcentral.nih.gov Exendin 4 (Ex4) is a glucagon-like peptide-1 receptor (GLP- 1R) agonist which is
available as a short-acting injectable treatment for type 2 diabetes. Our aim
was to characterize the long-term effects of elevated steady-state levels ... Cited by 1 - Related articles - All 5 versions
I Hadjiyanni, DJ Drucker - Endocrinology, 2007 - Endocrine Soc Diabetes mellitus is considered the epidemic of the 21st century, affecting
close to 170 million people in 2000, and expected to double in incidence by 2030
(1). The two major types of diabetes (types 1 and 2) are characterized by ... Cited by 2 - Related articles - BL Direct - All 2 versions
FA Adatia, LL Baggio, Q Xiao, DJ Drucker, PL … - Endocrinology, 2002 - Endocrine Soc Glucagon-like peptide-1 (GLP-1) is a potent stimulator of glucose-dependent
insulin secretion. Exendin-4 1–39 (Ex-4), isolated from Gila monster venom, is
a highly specific GLP-1 receptor agonist that exhibits a prolonged duration ... Cited by 2 - Related articles - BL Direct - All 6 versions
K Oka, L Chan - Current protocols in human genetics/editorial board, …, 2005 - ncbi.nlm.nih.gov The helper-dependent adenovirus (HDAd) is a recently developed adenovirus-based
vector with an improved safety profile and long-term transgene expression. In
this unit, a basic procedure for HDAd production using the Cre-loxP system ... Cited by 2 - Related articles - All 2 versions
N Sun, G Yang, H Zhao, HFJ Savelkoul, L An - Mediators of Inflammation, 2005 - hindawi.com Mediators of Inflammation • 2005:4 (2005) 202–209 • PII: S0962935105506082
• DOI: 10.1155/MI.2005.202 RESEARCH COMMUNICATION ... Naxin Sun, 1 Guiwen
Yang, 1 Heng Zhao, 2 Huub FJ Savelkoul, 2 and Liguo An 1 Cited by 3 - Related articles - View as HTML - BL Direct - All 12 versions
- ►publicationslist.org [PDF] MS Islam, SMA Rahman, Z Mirzaei, KB Islam - Life sciences, 2005 - Elsevier Type 2 diabetes is a polygenic disorder characterized by increased insulin
resistance, and impaired insulin secretion leading to abnormalities of glucose
and lipid metabolism. Reduced responsiveness of the β-cells to glucose is ... Cited by 3 - Related articles - All 7 versions
T Tomita - Endocrine Pathology, 1999 - Springer Glucose is a major metabolic fuel in mammals and is transported into organs and
cells by a facilitated diffusion which involves binding of glucose to glucose
transporters (GLUTs). Among several GLUTs so far indentified, GLUT-2 is ... Cited by 5 - Related articles - BL Direct - All 2 versions
L Li, G Yang, Q Li, X Tan, H Liu, Y Tang, G … - Diabetes Obes Metab, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 6 - Related articles - All 2 versions
S Aja, C Ewing, J Lin, J Hyun, TH Moran - Peptides, 2006 - Elsevier Central administration of both CART and GLP-1 reduces feeding and increases
c-Fos in brain areas associated with food intake. To determine whether aspects
of CART's effects were mediated through GLP-1's action, we examined whether ... Cited by 5 - Related articles - All 4 versions
